🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

29 recruiting trials

for Myopia Progression

Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis NCT06992622n/a1 site📍 Wenzhou Second Affiliated Hospital of Wenzhou Medical University Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression NCT07522242Phase 210 sites📍 Amman📍 Amman📍 Amman Laboratoires Thea · Tests: T10430 lower dose, T10430 middle dose, T10430 higher dose, Vehicle Effect of MiYOSMART iQ Spectacle Lenses on Myopia Progression in Children NCT07387159NA1 site📍 Moscow Hoya Lens Rus LLC · Tests: MiYOSMART iQ spectacle lenses A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children NCT06305663NA11 sites📍 Beijing📍 Dongcheng📍 Xiamen Bausch & Lomb Incorporated · Tests: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic), CooperVision MiSight (omafilcon A/60%) Myopia Control o… Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia NCT06344572NA1 site📍 Incheon S-Alpha Therapeutics, Inc. · Tests: SAT-001, Single vision spectacles Pharmacological and Non-pharmacological Treatment Effects on Children With Different Predicted Myopia Progression Rate NCT06282848NA1 site📍 Hong Kong The Hong Kong Polytechnic University · Tests: Atropine 0.05%, DIMS lens Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children. NCT06389110Phase 31 site📍 Mexico City Laboratorios Sophia S.A de C.V. · Tests: Alleance®, Placebo Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses NCT07229352NA1 site📍 Glendale SightGlass Vision, Inc. · Tests: Novel spectacle lens design, Spectacle lenses Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression NCT06717048NA1 site📍 Shanghai Shanghai Eye Disease Prevention and Treatment Center · Tests: Repeated Low-level Red-light, Red LED A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control NCT07095894Phase 318 sites📍 Birmingham📍 Tucson📍 Fullerton Jaeb Center for Health Research · Tests: Atropine, Spectacles with HAL, Placebo Eyedrops Influence of Rodenstock Spectacle Lenses on Myopia Progression. NCT06816446NA1 site📍 Singapore Rodenstock GmbH · Tests: Myopia control spectacle lens, Single-vision lens Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses NCT07021560NA1 site📍 Hanoi ZEISS Vision Care · Tests: ZEISS MyoCare spectacle lenses, ZEISS SV RX SPH 1.5, ZEISS Clearview Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children NCT06742268n/a5 sites📍 Seoul📍 Seoul📍 Hwaseong-si S-Alpha Therapeutics, Inc. · Tests: Single vision spectacles Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years NCT07462897NA1 site📍 Paris Essilor International · Tests: MCL1, MCL2 Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY) NCT07028827Phase 311 sites📍 Tirana📍 Bari📍 Milan Ocus Innovation Ireland Limited · Tests: 0.05% atropine eye drops, 0.025% atropine eye drops, placebo eye drops Guangke Lenses in Congenital Cataract NCT07778797NA1 site📍 Shanghai Eye & ENT Hospital of Fudan University · Tests: Conventional Bifocal Lenses, Individually Customized Bifocal + Defocus Lenses Atropine in the Treatment of Myopia Study in Malaysia NCT07329777Phase 32 sites📍 Kuala Lumpur📍 Kuala Lumpur IDB VisionCare SDN BHD · Tests: Low dose atropine sulfate eye drops, Placebo A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children NCT06151587Phase 31 site📍 Wenzhou Qilu Pharmaceutical Co., Ltd. · Tests: QLM3004 Concentration 1, QLM3004 Concentration 2, QLM3004 Concentration 3, Placebo Electronic Spectacles Versus Low Dose Atropine in Young Myopes NCT06034379NA1 site📍 Hsinchu Kubota Vision Inc. · Tests: eSpectacle Clinical prototype (CP1) device, 0.01% atropine Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia NCT07298824Phase 21 site📍 Nanchang Second Affiliated Hospital of Nanchang University · Tests: Investigational Bifidobacterium Preparation MR-61, Placebo for MR-61 Factors Influencing Physiological Hyperopia in Children NCT06498947n/a1 site📍 Beijing Beijing Tongren Hospital · Tests: This study was observational with no intervention. Inhibition of Myopia Progression With Optical Devices NCT07698977n/a1 site📍 Budapest Semmelweis University · Tests: Wearing myopia-control D.I.M.S. glasses while awake, DIMS (Defocus Incorporated Multiple Segments) lenses Clinical Investigation of a Novel Spectacle Lens on Slowing Down Juvenile Myopia Progression NCT06850168NA1 site📍 Singapore Essilor International · Tests: SVL, SVL with passive red-light emission, MCL, MCL with passive red-light emission Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens NCT06034327NA14 sites📍 Oakland📍 San Diego📍 San Francisco SightGlass Vision, Inc. · Tests: Single vision, impact-resistant spectacle lenses; Test Arm, Single vision, impact-resistant spectacle lenses; Control A… Association of Genetic Variants With Myopia NCT07030153n/a2 sites📍 Beijing📍 Beijing Beijing Visionly Plus Eye Hospital · Tests: Oral swab DNA analyzed for myopia-related gene variants Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN) NCT06631339NA5 sites📍 Singapore📍 Singapore📍 Singapore National University of Singapore · Tests: Light Intervention, Digital Intervention, Control Group Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression NCT07323251NA1 site📍 Beijing Beijing Tongren Hospital · Tests: Diverse Segments Defocus Optimization (D.S.D.O.) spectacle lenses The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression NCT06708156Phase 325 sites📍 Hefei📍 Hefei📍 Xuancheng Oupushifang Pharmaceutical Technology Co., Ltd. · Tests: Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops Children's Viewing Behavior NCT07229365NA1 site📍 Bloomington SightGlass Vision, Inc. · Tests: Novel spectacle lens design, Spectacle lenses
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy